Advertisement

Dosing of Peritoneal Dialysis

Chapter

Abstract

Peritoneal dialysis can be performed either manually (continuous ambulatory peritoneal dialysis, CAPD) or by using a cycler (automated peritoneal dialysis, APD). The targets for adequate dialysis (solute and fluid removal) are reviewed. The impact of the velocity of peritoneal solute transport for the choice between CAPD and APD is highlighted. Then the effects of changing various modifiable treatment parameters such as fill volume, dwell time, and number of dwells are discussed. Thereafter, advice is given on how to stepwise improve the adequacy of CAPD and APD. The indications for tidal peritoneal dialysis (TPD) are discussed. Finally, the impact of CAPD and APD on sodium removal is underlined.

Keywords

CAPD APD TPD Adequacy Peritoneal transport Sodium removal Treatment modalities 

References

  1. 1.
    Scribner BH. Some thoughts on research to define adequacy of dialysis. Kidney Int Suppl. 1975;2:3–6.PubMedGoogle Scholar
  2. 2.
    Wang T, Heimburger O, Waniewski J, Bergström J, Lindholm B. Increased peritoneal permeability is associated with decreased fluid and small solute removal and higher mortality in CAPD patients. Nephrol Dial Transpl. 1998;13(5):1242–9.CrossRefGoogle Scholar
  3. 3.
    Struijk DG. Volume status in CAPD and APD: does treatment modality matter and is more always better? Perit Dial Int. 2007;27(6):641–4.PubMedGoogle Scholar
  4. 4.
    Dombros N, Dratwa M, Feriani M, Gokal R, Heimbürger O, Krediet R, Plum J, Rodrigues A, Selgas R, Struijk D, Verger C, EBPG Expert Group on Peritoneal Dialysis. European best practice guidelines for peritoneal dialysis. 7 Adequacy of peritoneal dialysis. Nephrol Dial Transpl. 2005;20(Suppl 9):24–7.Google Scholar
  5. 5.
    Lo WK, Bargman JM, Burkart J, Krediet RT, Pollock C, Kawanishi H, Blake PG. ISPD Adequacy of Peritoneal Dialysis Working Group. Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis. Perit Dial Int. 2006;26(5):520–2.PubMedGoogle Scholar
  6. 6.
    Peritoneal Dialysis Adequacy Work Group. Clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis. 2006;48(Suppl 1):98–129.CrossRefGoogle Scholar
  7. 7.
    Blake PG, Bargman JM, Brimble KS, Davison SN, Hirsch D, McCormick BB, Suri RS, Taylor P, Zalunardo N, Tonelli M. Canadian Society of Nephrology Work Group on adequacy of peritoneal dialysis. Perit Dial Int. 2011;31(2):218–39.PubMedGoogle Scholar
  8. 8.
    Bargman JM, Thorpe KE, Churchill DN, CANUSA Peritoneal Dialysis Study Group. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol. 2001;12(10):2158–62.PubMedGoogle Scholar
  9. 9.
    Termorshuizen F, Korevaar JC, Dekker FW, van Manen JG, Boeschoten EW, Krediet RT, NECOSAD Study Group. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands cooperative study on the adequacy of dialysis (NECOSAD)-2. Am J Kidney Dis. 2003;41(6):1293–302.CrossRefPubMedGoogle Scholar
  10. 10.
    Paniagua R, Amato D, Vonesh E, Correa–Rotter R, Ramos A, Moran J, et al. On behalf of the Mexican nephrology collaborative study group. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002;13(5):1307–20.Google Scholar
  11. 11.
    Lo WK, Ho YW, Li CS, Wong KS, Chan TM, Yu AW, et al. Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study. Kidney Int. 2003;64(2):649–56.CrossRefPubMedGoogle Scholar
  12. 12.
    Jansen MA, Termorshuizen F, Korevaar JC, Dekker FW, Boeschoten E, Krediet RT, NECOSAD Study Group. Predictors of survival in anuric peritoneal dialysis patients. Kidney Int. 2005;68(3):1199–205.CrossRefPubMedGoogle Scholar
  13. 13.
    Konings CJ, Kooman JP, Schonck M, Dammers R, Cheriex E, Palmans Meulemans AP, et al. Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis. Perit Dial Int. 2002;22(4):477–87.PubMedGoogle Scholar
  14. 14.
    Enia G, Mallamaci F, Benedetto FA, Panuccio V, Parlongo S, Cutrupi S, et al. Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol Dial Transpl. 2001;16(7):1459–64.CrossRefGoogle Scholar
  15. 15.
    Coester AM, Smit W, Struijk DG, Krediet RT. Peritoneal function in clinical practice: the importance of follow-up and its measurement in patients. Recommendations for patient information and measurement of peritoneal function. NDT Plus. 2009;2(2):104–10.PubMedPubMedCentralGoogle Scholar
  16. 16.
    Mujais S, Nolph K, Gokal R, Blake P, Burkart J, Coles G, et al. Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on ultrafiltration management in peritoneal dialysis. Perit Dial Int. 2000;20(Suppl 4):5–21.Google Scholar
  17. 17.
    Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LP, Moore HL, Nielsen MP. Peritoneal equilibration test. Perit Dial Bull. 1987;7:138–47.Google Scholar
  18. 18.
    Davies SJ, Brown B, Bryan J, Russell GI. Clinical evaluation of the peritoneal equilibration test: a population-based study. Nephrol Dial Transpl. 1993;8(1):64–70.Google Scholar
  19. 19.
    Keshaviah P, Emerson PF, Vonesh EF, Brandes JC. Relationship between body size, fill volume, and mass transfer area coefficient in peritoneal dialysis. J Am Soc Nephrol. 1994;4(10):1820–6.PubMedGoogle Scholar
  20. 20.
    Krediet RT, Boeschoten EW, Struijk DG, Arisz L. Differences in the peritoneal transport of water, solutes and proteins between dialysis with two- and with three-litre exchanges. Nephrol Dial Transpl. 1988;3(2):198–204.Google Scholar
  21. 21.
    Paniagua R, Ventura Mde J, Rodríguez E, Sil J, Galindo T, Hurtado ME, Alcántara G, Chimalpopoca A, González I, Sanjurjo A, Barrón L, Amato D, Mujais S. Impact of fill volume on peritoneal clearances and cytokine appearance in peritoneal dialysis. Perit Dial Int. 2004;24(2):156–62.PubMedGoogle Scholar
  22. 22.
    Durand PY, Chanliau J, Gamberoni J, Hestin D, Kessler M. Intraperitoneal pressure, peritoneal permeability and volume of ultrafiltration in CAPD. Adv Perit Dial. 1992;8:22–5.PubMedGoogle Scholar
  23. 23.
    Imholz AL, Koomen GC, Struijk DG, Arisz L, Krediet RT. Effect of an increased intraperitoneal pressure on fluid and solute transport during CAPD. Kidney Int. 1993;44(5):1078–85.CrossRefPubMedGoogle Scholar
  24. 24.
    Sarkar S, Bernardini J, Fried L, Johnston JR, Piraino B. Tolerance of large exchange volumes by peritoneal dialysis patients. Am J Kidney Dis. 1999;33(6):1136–41.CrossRefPubMedGoogle Scholar
  25. 25.
    de Jesús VM, Amato D, Correa-Rotter R, Paniagua R. Relationship between fill volume, intraperitoneal pressure, body size, and subjective discomfort perception in CAPD patients. Mexican nephrology collaborative study group. Perit Dial Int. 2000;20(2):188–93.Google Scholar
  26. 26.
    Harris KP, Keogh AM, Alderson L. Peritoneal dialysis fill volume: can the patient tell the difference? Perit Dial Int. 2001;21(Suppl 3):144–7.Google Scholar
  27. 27.
    Durand PY, Chanliau J, Gamberoni J, Hestin D, Kessler M. Routine measurement of hydrostatic intraperitoneal pressure. Adv Perit Dial. 1992;8:108–12.PubMedGoogle Scholar
  28. 28.
    Durand PY, Chanliau J, Gamberoni J, Hestin D, Kessler M. APD: clinical measurement of the maximal acceptable intraperitoneal volume. Adv Perit Dial. 1994;10:63–7.PubMedGoogle Scholar
  29. 29.
    Dejardin A, Robert A, Goffin E. Intraperitoneal pressure in PD patients: relationship to intraperitoneal volume, body size and PD-related complications. Nephrol Dial Transpl. 2007;22(5):1437–44.CrossRefGoogle Scholar
  30. 30.
    Krediet RT, Douma CE, van Olden RW, Ho-dac-Pannekeet MM, Struijk DG. Augmenting solute clearance in peritoneal dialysis. Kidney Int. 1998;54(6):2218–25.CrossRefPubMedGoogle Scholar
  31. 31.
    Szeto CC, Wong TY, Chow KM, Leung CB, Wang AY, Lui SF, Li PK. The impact of increasing the daytime dialysis exchange frequency on peritoneal dialysis adequacy and nutritional status of Chinese anuric patients. Perit Dial Int. 2002;22(2):197–203.PubMedGoogle Scholar
  32. 32.
    Kumano K, Yamashita A, Sakai T. Optimal number of dialysate exchanges in automated peritoneal dialysis. Adv Perit Dial. 1993;9:110–3.PubMedGoogle Scholar
  33. 33.
    Abu-Alfa AK, Burkart J, Piraino B, Pulliam J, Mujais S. Approach to fluid management in peritoneal dialysis: a practical algorithm. Kidney Int Suppl. 2002;81:8–16.CrossRefGoogle Scholar
  34. 34.
    Perez RA, Blake PG, McMurray S, Mupas L, Oreopoulos DG. What is the optimal frequency of cycling in automated peritoneal dialysis? Perit Dial Int. 2000;20(5):548–56.PubMedGoogle Scholar
  35. 35.
    Imholz AL, Koomen GC, Struijk DG, Arisz L, Krediet RT. Effect of dialysate osmolarity on the transport of low-molecular weight solutes and proteins during CAPD. Kidney Int. 1993;43(6):1339–46.CrossRefPubMedGoogle Scholar
  36. 36.
    Hendriks PM, Ho-dac-Pannekeet MM, van Gulik TM, Struijk DG, Phoa SS, Sie L, Kox C, Krediet RT. Peritoneal sclerosis in chronic peritoneal dialysis patients: analysis of clinical presentation, risk factors, and peritoneal transport kinetics. Perit Dial Int. 1997;17(2):136–43.PubMedGoogle Scholar
  37. 37.
    Davies SJ, Philips L, Naish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol. 2001;12(5):1046–51.PubMedGoogle Scholar
  38. 38.
    Krediet RT, Struijk DG. Peritoneal changes in patients on long-term peritoneal dialysis. Nat Rev Nephrol. 2013;9(7):419–29.CrossRefPubMedGoogle Scholar
  39. 39.
    Li FK, Chan LY, Woo JC, Ho SK, Lo WK, Lai KN, Chan TM. A 3-year, prospective, randomized, controlled study on amino acid dialysate in patients on CAPD. Am J Kidney Dis. 2003;42(1):173–83.CrossRefPubMedGoogle Scholar
  40. 40.
    Kopple JD, Bernard D, Messana J, Swartz R, Bergström J, Lindholm B, Lim V, Brunori G, Leiserowitz M, Bier DM, et al. Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int. 1995;47(4):1148–57.CrossRefPubMedGoogle Scholar
  41. 41.
    Douma CE, Hiralall JK, de Waart DR, Struijk DG, Krediet RT. Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells. Kidney Int. 1998;53(4):1014–21.CrossRefPubMedGoogle Scholar
  42. 42.
    Dousdampanis P, Trigka K, Bargman JM. Bimodal solutions or twice-daily icodextrin to enhance ultrafiltration in peritoneal dialysis patients. Int. J Nephrol. 2013;2013:424915. doi:10.1155/2013/424915.Google Scholar
  43. 43.
    Blake P, Burkart JM, Churchill DN, Daugirdas J, Depner T, Hamburger RJ, Hull AR, Korbet SM, Moran J, Nolph KD. Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int. 1996;16(5):448–56.PubMedGoogle Scholar
  44. 44.
    Davies SJ, Brown EA, Frandsen NE, Rodrigues AS, Rodriguez-Carmona A, Vychytil A, Macnamara E, Ekstrand A, Tranaeus A, Filho JC, EAPOS Group. Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription. Kidney Int. 2005;67(4):1609–15.CrossRefPubMedGoogle Scholar
  45. 45.
    Li PK, Culleton BF, Ariza A, Do JY, Johnson DW, Sanabria M, Shockley TR, Story K, Vatazin A, Verrelli M, Yu AW, Bargman JM; IMPENDIA and EDEN Study Groups. Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients. J Am Soc Nephrol. 2013;24(11):1889–900.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Mujais S, Childers RW. Profiles of automated peritoneal dialysis prescriptions in the US 1997–2003. Kidney Int Suppl. 2006;103:84–90.CrossRefGoogle Scholar
  47. 47.
    Vonesh EF, Keshaviah PR. Applications in kinetic modeling using PD ADEQUEST. Perit Dial Int. 1997;17(Suppl 2):S119–25.PubMedGoogle Scholar
  48. 48.
    Vonesh EF, Story KO, O’Neill WT. A multinational clinical validation study of PD ADEQUEST 2.0. PD ADEQUEST international study group. Perit Dial Int. 1999;19(6):556–71.PubMedGoogle Scholar
  49. 49.
    Vonesh EF, Story KO, Douma CE, Krediet RT. Modeling of icodextrin in PD Adequest 2.0. Perit Dial Int. 2006;26(4):475–81.PubMedGoogle Scholar
  50. 50.
    Demetriou D, Habicht A, Schillinger M, Hörl WH, Vychytil A. Adequacy of automated peritoneal dialysis with and without manual daytime exchange: a randomized controlled trial. Kidney Int. 2006;70(9):1649–55.CrossRefPubMedGoogle Scholar
  51. 51.
    Diaz-Buxo JA. Enhancement of peritoneal dialysis: the PD Plus concept. Am J Kidney Dis. 1996;27(1):92–8.CrossRefPubMedGoogle Scholar
  52. 52.
    Freida P, Issad B. Continuous cyclic peritoneal dialysis prescription and power. Contrib Nephrol. 1999;129:98–108.CrossRefPubMedGoogle Scholar
  53. 53.
    Rodríguez-Carmona A, Pérez Fontán M, García López E, García Falcón T, Díaz Cambre H. Use of icodextrin during nocturnal automated peritoneal dialysis allows sustained ultrafiltration while reducing the peritoneal glucose load: a randomized crossover study. Perit Dial Int. 2007;27(3):260–6.PubMedGoogle Scholar
  54. 54.
    Gobin J, Fernando S, Santacroce S, Finkelstein FO. The utility of two daytime icodextrin exchanges to reduce dextrose exposure in automated peritoneal dialysis patients: a pilot study of nine patients. Blood Purif. 2008;26(3):279–83.CrossRefPubMedGoogle Scholar
  55. 55.
    Brandes JC, Packard WJ, Watters SK, Fritsche C. Optimization of dialysate flow and mass transfer during automated peritoneal dialysis. Am J Kidney Dis. 1995;25(4):603–10.CrossRefPubMedGoogle Scholar
  56. 56.
    Vychytil A, Hörl WH. The role of tidal peritoneal dialysis in modern practice: A European perspective. Kidney Int Suppl. 2006;103:96–103. Review.CrossRefGoogle Scholar
  57. 57.
    Cižman B, Lindo S, Bilionis B, Davis I, Brown A, Miller J, Phillips G, Kriukov A, Sloand JA. The occurrence of increased intraperitoneal volume events in automated peritoneal dialysis in the US: role of programming, patient/user actions and ultrafiltration. Perit Dial Int. 2014;34(4):434–42. doi:10.3747/pdi.2013.01157.CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Struijk DG, Krediet RT. Sodium balance in automated peritoneal dialysis. Perit Dial Int. 2000;20(Suppl 2):S101–5.PubMedGoogle Scholar
  59. 59.
    Rodríguez-Carmona A, Fontán MP. Sodium removal in patients undergoing CAPD and automated peritoneal dialysis. Perit Dial Int. 2002;22(6):705–13.PubMedGoogle Scholar
  60. 60.
    Rodriguez-Carmona A, Pérez-Fontán M, Garca-Naveiro R, Villaverde P, Peteiro J. Compared time profiles of ultrafiltration, sodium removal, and renal function in incident CAPD and automated peritoneal dialysis patients. Am J Kidney Dis. 2004;44(1):132–45.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2016

Authors and Affiliations

  1. 1.Department of NephrologyDianet, Academic Medical CenterAmsterdamThe Netherlands

Personalised recommendations